Proto Labs, Inc. (PRLB) Stock Forecast
PRLB analyst forecast
as of October 17, 2026- Analyst consensus
- Buy 4.40 / 5 from 5 analysts
- Price target
- $95.50 average of analyst targets
- Upside to target
- +11.5% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $0.43
- 52-week range
- $46.81 – $98.68
PRLB analyst ratings
5 analystsNumber of analysts at each rating.
PRLB price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PRLB earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.60 | $0.59 | $0.60 | $0.47 | +26.8% | 5 |
| Current fiscal year (2026) | $2.21 | $2.20 | $2.25 | $1.66 | +33.4% | 5 |
| Next fiscal year (2027) | $2.39 | $2.35 | $2.47 | $2.21 | +7.8% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PRLB revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $149.0M | $148.7M | $149.2M | +10.1% | 5 |
| Current fiscal year (2026) | $582.4M | $581.4M | $584.4M | +9.2% | 5 |
| Next fiscal year (2027) | $626.5M | $622.3M | $634.8M | +7.6% | 4 |
PRLB EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PRLB revenue: reported and forecast
PRLB EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.52 | $0.52 | $0.52 | $0.52 | $0.60 | +14.1% | 4 up · 0 down |
| Current fiscal year (2026) | $2.04 | $2.04 | $2.04 | $2.04 | $2.21 | +8.5% | 4 up · 0 down |
| Next fiscal year (2027) | $2.21 | $2.21 | $2.21 | $2.21 | $2.39 | +8.2% | 4 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PRLB earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PRLB beat in 11 of 12.
What analysts expect from PRLB
5 analysts cover Proto Labs; their consensus rating is buy (4.40 on a 1–5 scale, where 5 is a strong buy). The average price target is $95.50, 11.5% above the latest close of $85.65. Analysts expect earnings of $2.21 per share for 2026, +33.4% from a year earlier. For 2027 the average estimate is $2.39 per share on revenue of $626.5 million. Proto Labs beat the EPS estimate in 11 of the last 12 quarters.
Related: PRLB income statement, PRLB key metrics, PRLB chart. See the PRLB stock overview for the latest quote and news.
PRLB forecast FAQ
What is Proto Labs's price target?
The average analyst price target for Proto Labs is $95.50, 11.5% above the latest close of $85.65.
Is Proto Labs a buy, hold or sell?
Of 5 analysts covering Proto Labs, 3 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Proto Labs's EPS forecast?
Analysts forecast $2.21 per share for 2026 (range $2.20 to $2.25); for 2027 the estimate is $2.39.
What is Proto Labs's revenue forecast?
The average revenue estimate for 2026 is $582.4 million, growth of 9.2%; for 2027 it is $626.5 million.
When does Proto Labs report earnings?
Proto Labs is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 before the market opens; the EPS estimate is $0.43.
Does Proto Labs usually beat earnings estimates?
Proto Labs reported EPS at or above the analyst estimate in 11 of the last 12 quarters.